+1 347 708 0418
Plasma Protease C1-inhibitor Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Plasma Protease C1-inhibitor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
C1-inhibitors
Kallikrein Inhibitor (Kalbitor)
Segment by Application
Hospital Pharmacies
Independent Pharmacies and Outlets
By Company
Takeda
CSL
Sanquin
Pharming Group
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 C1-inhibitors
1.2.3 Kallikrein Inhibitor (Kalbitor)
1.3 Market by Application
1.3.1 Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies and Outlets
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasma Protease C1-inhibitor Treatment Market Perspective (2017-2028)
2.2 Plasma Protease C1-inhibitor Treatment Growth Trends by Region
2.2.1 Plasma Protease C1-inhibitor Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasma Protease C1-inhibitor Treatment Historic Market Size by Region (2017-2022)
2.2.3 Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028)
2.3 Plasma Protease C1-inhibitor Treatment Market Dynamics
2.3.1 Plasma Protease C1-inhibitor Treatment Industry Trends
2.3.2 Plasma Protease C1-inhibitor Treatment Market Drivers
2.3.3 Plasma Protease C1-inhibitor Treatment Market Challenges
2.3.4 Plasma Protease C1-inhibitor Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue
3.1.1 Global Top Plasma Protease C1-inhibitor Treatment Players by Revenue (2017-2022)
3.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Plasma Protease C1-inhibitor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasma Protease C1-inhibitor Treatment Revenue
3.4 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio
3.4.1 Global Plasma Protease C1-inhibitor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasma Protease C1-inhibitor Treatment Revenue in 2021
3.5 Plasma Protease C1-inhibitor Treatment Key Players Head office and Area Served
3.6 Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
3.7 Date of Enter into Plasma Protease C1-inhibitor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasma Protease C1-inhibitor Treatment Breakdown Data by Type
4.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Type (2017-2022)
4.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028)
5 Plasma Protease C1-inhibitor Treatment Breakdown Data by Application
5.1 Global Plasma Protease C1-inhibitor Treatment Historic Market Size by Application (2017-2022)
5.2 Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
6.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Type
6.2.1 North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022)
6.2.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028)
6.2.3 North America Plasma Protease C1-inhibitor Treatment Market Share by Type (2017-2028)
6.3 North America Plasma Protease C1-inhibitor Treatment Market Size by Application
6.3.1 North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022)
6.3.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028)
6.3.3 North America Plasma Protease C1-inhibitor Treatment Market Share by Application (2017-2028)
6.4 North America Plasma Protease C1-inhibitor Treatment Market Size by Country
6.4.1 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
6.4.2 North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
7.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type
7.2.1 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022)
7.2.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028)
7.2.3 Europe Plasma Protease C1-inhibitor Treatment Market Share by Type (2017-2028)
7.3 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application
7.3.1 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022)
7.3.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028)
7.3.3 Europe Plasma Protease C1-inhibitor Treatment Market Share by Application (2017-2028)
7.4 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country
7.4.1 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
7.4.2 Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
8.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type
8.2.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application
8.3.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region
8.4.1 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
9.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type
9.2.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Plasma Protease C1-inhibitor Treatment Market Share by Type (2017-2028)
9.3 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application
9.3.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Plasma Protease C1-inhibitor Treatment Market Share by Application (2017-2028)
9.4 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country
9.4.1 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size (2017-2028)
10.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type
10.2.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application
10.3.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country
10.4.1 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Takeda
11.1.1 Takeda Company Details
11.1.2 Takeda Business Overview
11.1.3 Takeda Plasma Protease C1-inhibitor Treatment Introduction
11.1.4 Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.1.5 Takeda Recent Developments
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Plasma Protease C1-inhibitor Treatment Introduction
11.2.4 CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.2.5 CSL Recent Developments
11.3 Sanquin
11.3.1 Sanquin Company Details
11.3.2 Sanquin Business Overview
11.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Introduction
11.3.4 Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.3.5 Sanquin Recent Developments
11.4 Pharming Group
11.4.1 Pharming Group Company Details
11.4.2 Pharming Group Business Overview
11.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Introduction
11.4.4 Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
11.4.5 Pharming Group Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of C1-inhibitors
Table 3. Key Players of Kallikrein Inhibitor (Kalbitor)
Table 4. Global Plasma Protease C1-inhibitor Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2017-2022)
Table 8. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Plasma Protease C1-inhibitor Treatment Market Share by Region (2023-2028)
Table 10. Plasma Protease C1-inhibitor Treatment Market Trends
Table 11. Plasma Protease C1-inhibitor Treatment Market Drivers
Table 12. Plasma Protease C1-inhibitor Treatment Market Challenges
Table 13. Plasma Protease C1-inhibitor Treatment Market Restraints
Table 14. Global Plasma Protease C1-inhibitor Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Plasma Protease C1-inhibitor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
Table 17. Ranking of Global Top Plasma Protease C1-inhibitor Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasma Protease C1-inhibitor Treatment Product Solution and Service
Table 21. Date of Enter into Plasma Protease C1-inhibitor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Plasma Protease C1-inhibitor Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Application (2017-2022)
Table 29. Global Plasma Protease C1-inhibitor Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Application (2023-2028)
Table 31. North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Takeda Company Details
Table 62. Takeda Business Overview
Table 63. Takeda Plasma Protease C1-inhibitor Treatment Product
Table 64. Takeda Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 65. Takeda Recent Developments
Table 66. CSL Company Details
Table 67. CSL Business Overview
Table 68. CSL Plasma Protease C1-inhibitor Treatment Product
Table 69. CSL Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 70. CSL Recent Developments
Table 71. Sanquin Company Details
Table 72. Sanquin Business Overview
Table 73. Sanquin Plasma Protease C1-inhibitor Treatment Product
Table 74. Sanquin Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 75. Sanquin Recent Developments
Table 76. Pharming Group Company Details
Table 77. Pharming Group Business Overview
Table 78. Pharming Group Plasma Protease C1-inhibitor Treatment Product
Table 79. Pharming Group Revenue in Plasma Protease C1-inhibitor Treatment Business (2017-2022) & (US$ Million)
Table 80. Pharming Group Recent Developments
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Protease C1-inhibitor Treatment Market Share by Type: 2021 VS 2028
Figure 2. C1-inhibitors Features
Figure 3. Kallikrein Inhibitor (Kalbitor) Features
Figure 4. Global Plasma Protease C1-inhibitor Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Independent Pharmacies and Outlets Case Studies
Figure 7. Plasma Protease C1-inhibitor Treatment Report Years Considered
Figure 8. Global Plasma Protease C1-inhibitor Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Plasma Protease C1-inhibitor Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Plasma Protease C1-inhibitor Treatment Market Share by Region: 2021 VS 2028
Figure 11. Global Plasma Protease C1-inhibitor Treatment Market Share by Players in 2021
Figure 12. Global Top Plasma Protease C1-inhibitor Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Protease C1-inhibitor Treatment as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2021
Figure 14. North America Plasma Protease C1-inhibitor Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2017-2028)
Figure 16. North America Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2017-2028)
Figure 17. North America Plasma Protease C1-inhibitor Treatment Market Size Share by Country (2017-2028)
Figure 18. United States Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Plasma Protease C1-inhibitor Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2017-2028)
Figure 22. Europe Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2017-2028)
Figure 23. Europe Plasma Protease C1-inhibitor Treatment Market Size Share by Country (2017-2028)
Figure 24. Germany Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Plasma Protease C1-inhibitor Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Plasma Protease C1-inhibitor Treatment Market Size Share by Region (2017-2028)
Figure 34. China Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Plasma Protease C1-inhibitor Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Plasma Protease C1-inhibitor Treatment Market Size Share by Country (2017-2028)
Figure 44. Mexico Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Plasma Protease C1-inhibitor Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Plasma Protease C1-inhibitor Treatment Market Size Share by Country (2017-2028)
Figure 50. Turkey Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Plasma Protease C1-inhibitor Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Takeda Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 54. CSL Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 55. Sanquin Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 56. Pharming Group Revenue Growth Rate in Plasma Protease C1-inhibitor Treatment Business (2017-2022)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Buy
